Form 4: Insmed Director Elizabeth M. Anderson Reports Acquisition of Restricted Stock Units

Director Elizabeth M. Anderson reports acquisition of 5,058 Restricted Stock Units (RSUs) in Insmed Inc.

Summary

• On May 15, 2025, Elizabeth M. Anderson, a director of Insmed Inc., acquired 5,058 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Insmed's common stock.
• The RSUs vest after one year, contingent upon Anderson remaining a board member and attending at least 75% of board meetings.
• Following the transaction, Anderson beneficially owns 73,729 shares of Insmed common stock directly.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. The acquisition of RSUs by a director is generally viewed as a positive sign, but it's a routine occurrence.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the RSUs is contingent upon continued service on the board and attendance at board meetings, aligning the director's interests with the company's long-term success.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be informative for investors.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates

Keywords

Insmed, Director, RSU, Restricted Stock Units, Beneficial Ownership, Form 4, Elizabeth M. Anderson